Industrial Manufacturing is no longer defined by operational excellence alone. Discover how leading organizations are achieving measurable EBIT impact through Commercial Transformation and AI Powered decision systems.

Fernando Ventureira will be in Amsterdam next week. Coffee or dinner with local business leaders.

In Medical Devices, margin erosion rarely comes from innovation. It comes from fragmented commercial governance. Stratence Partners explains how Commercial Transformation, AI Powered, restores structural control and delivers measurable EBIT impact within year one.

SPIE in Oil & Gas restores pricing discipline, deal transparency and commercial execution control in volatile energy markets.

At EPA 2026, Stratence Partners will lead two executive sessions on Gross-to-Net discipline and AI-driven commercial transformation — focused on execution, governance and measurable impact.

Meet Stratence Partners in 2026 | Commercial Transformation & Pricing Events

Commercial performance does not come from isolated initiatives. It emerges from how Strategy, Pricing and Commercial Execution operate together as an integrated decision system.

SPIE in Chemicals provides a unified commercial ecosystem to regain control over pricing, execution and margin discipline in volatile markets.

Volatility has become structural in the Chemical industry. This article explores how leading players are strengthening pricing governance and commercial execution to protect margins and turn complexity into competitive advantage.